Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS)

Market Cap	100.75B
Revenue (ttm)	40.83B
Net Income (ttm)	2.78B
Shares Out	157.39M
EPS (ttm)	19.21
PE Ratio	33.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,476
Open	640.10
Previous Close	609.65
Day's Range	640.10 - 640.10
52-Week Range	530.05 - 1,175.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About AKUMS

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 7,388
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AKUMS